JPRN-UMIN000000489已完成2 期
Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor - Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor
agoya University of School of Medicine Breast and Endocrine Surgery0 个研究点目标入组 40 人开始时间: 2006年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.brain metastasis 2.bilateral brest cancer 3.male breast cancer 4.severe allergy 5.severe complications
研究者
相似试验
已完成
2 期
Assessment of the Efficacy of High-Dose Toremifene 120mg Therapy for Anastorozole-resistant Postmenopausal Breast Cancer (SBCCSG-11)Postmenopausal breast cancerJPRN-UMIN000000967Saitama Breast Cancer Clinical Study Group (SBCCSG)40
进行中（未招募）
不适用
Evaluation of the efficacy of toremifene in desmoid tumor and identification of potential targetsEUCTR2011-006205-95-ITISTITUTO NAZIONALE PER LA CURA TUMORI
招募中
2 期
Effect of High-dose Toremifene for premenopausal metastatic breast cancerpremenopausal metastatic breast cancerJPRN-UMIN000002867Multi Hormone Study Group25
已完成
2 期
High-Dose TOREMIFENE for non-steroidal AI failureRecurrent breast cancerJPRN-UMIN000003178Hiroshima Breast Cancer Study Group60
已完成
2 期
Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast CancerBreast Cancer MetastaticNCT03045653Sun Yat-sen University30